Brief Psychological Intervention for Pancreatic Cancer During Neoadjuvant Therapy
This study is testing a brief psychological intervention to help improve emotional well-being for people with localized pancreatic cancer. Localized means the cancer has not spread to other parts of the body. You would be eligible if you are an adult (18 or older) with newly diagnosed localized pancreatic cancer and are planning to start neoadjuvant therapy (treatment like chemotherapy or radiation before surgery). This intervention involves meeting with a psychologist via telehealth once a week for four weeks. The main goal is to see if this intervention is practical and acceptable to patients, and if it can help with quality of life and reduce stress or anxiety. The study is planning to enroll 60 participants, but its current status is unclear.
- Study design
- This is an interventional study with 60 planned participants. It is testing a psychosocial oncology intervention.
- What's involved
- You would participate in a psychosocial oncology intervention, meeting with a psychologist via telehealth for 40 minutes once a week for 4 weeks. You would also receive referrals for standard physical and nutritional therapy.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, feasibility and acceptability, will be measured for up to 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
At a glance
Conditions
NCT07124611
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Ohio State University Comprehensive Cancer Center
Columbus, Ohiostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jordan M Cloyd, MD · PRINCIPAL_INVESTIGATOR · Ohio State University Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility and acceptability of the psychosocial oncology interventionUp to 1 year
Will be defined as the proportion of enrolled patients who complete the intervention and report that it was acceptable. Will define the incorporation of psychosocial oncology into prehab as feasible and acceptable if \>= 70% of enrolled participants agree.